Evidence map›Paper›PMID 33377985›Full record

ReviewHerz2021

Heart and kidney disease: a cardiovascular high-risk constellation.

Stefan J Schunk, Thimoteus Speer, Danilo Fliser

Abstract readReview
PubMed Publisher
In one paragraph

Review in Herz, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 75% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Stefan J SchunkKlinik für Innere Medizin IV, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany. stefan.schunk@uks.eu.
Thimoteus SpeerKlinik für Innere Medizin IV, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany.
Danilo FliserKlinik für Innere Medizin IV, Universitätsklinikum des Saarlandes, Homburg/Saar, Germany.
Universitätsklinikum des Saarlandes · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic kidney disease (CKD) is associated with substantial cardiovascular morbidity and mortality. This is mediated by highly prevalent traditional cardiovascular risk factors such as arterial hypertension and diabetes mellitus in patients with CKD, but also by the presence of CKD-specific so-called nontraditional cardiovascular risk factors such as vascular calcification, uremic toxins, uremic dyslipidemia, inflammation, and oxidative stress. Therefore, the primary and secondary prevention of cardiovascular disease represents an important part of the care of patients with CKD. This entails optimal control of blood pressure and diabetes, treatment of the uremic dyslipidemia, as well as life-style modifying factors such as weight reduction and smoking cessation.

Indexed as

Cardiovascular DiseasesDyslipidemiasHypertensionRenal Insufficiency, ChronicBlood PressureHumansRisk FactorsArterial hypertensionDiabetes mellitusDyslipidemiaRenal insufficiency, chronicRisk factors

Identifiers

PMID33377985
OpenAlexW3117110158

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.